US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
EP2266542A3
(en)
*
|
1998-10-01 |
2013-07-31 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
EP1128817A1
(en)
*
|
1998-10-27 |
2001-09-05 |
Biovail Technologies Ltd |
Microparticles containing peg and/or peg glyceryl esters
|
US7815937B2
(en)
*
|
1998-10-27 |
2010-10-19 |
Biovail Laboratories International Srl |
Quick dissolve compositions and tablets based thereon
|
PT1126826E
(en)
|
1998-11-02 |
2008-11-25 |
Elan Pharma Int Ltd |
Multiparticulate modified release composition of methylphenidate
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
DE19931708A1
(en)
|
1999-07-08 |
2001-01-18 |
Bayer Ag |
Process for the preparation of rapidly disintegrating solid pharmaceutical preparations
|
AR028253A1
(en)
*
|
2000-03-16 |
2003-04-30 |
Pfizer Prod Inc |
INHIBITORS OF THE GLUCOGENO FOSFORILASA
|
US7575761B2
(en)
*
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
US6656492B2
(en)
*
|
2000-06-30 |
2003-12-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Quick disintegrating tablet in buccal cavity and manufacturing method thereof
|
US20100010101A1
(en)
*
|
2000-07-05 |
2010-01-14 |
Capricorn Pharma, Inc. |
Rapid-Melt Compositions and Methods of Making Same
|
AU2001277230A1
(en)
*
|
2000-08-01 |
2002-02-13 |
Inhale Therapeutic Systems, Inc. |
Apparatus and process to produce particles having a narrow size distribution andparticles made thereby
|
CN1638739A
(en)
*
|
2000-08-18 |
2005-07-13 |
法玛西雅厄普约翰美国公司 |
Compound for treating assuetude disturbance
|
US20040043061A1
(en)
*
|
2000-09-15 |
2004-03-04 |
Leon Daniel S. |
Dissolvable films comprising suspended, non-soluble pharmaceutically active ingredients, apparatus and methods for their manufacture and use
|
US7198795B2
(en)
*
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
US6982251B2
(en)
*
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6559180B2
(en)
|
2001-03-27 |
2003-05-06 |
Yuri Busiashvili |
Nitroglycerin-menthol potentiation for treatment of angina
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
ATE291899T1
(en)
*
|
2001-06-22 |
2005-04-15 |
Marie Lindner |
HIGH THROUGHPUT SCREENING PROCEDURE (HTS) USING LABORATORY MILLS OR MICROFLUIDICS
|
EP1275377B1
(en)
*
|
2001-07-11 |
2003-06-18 |
Apr Applied Pharma Research S.A. |
Granulates containing liposoluble substances and process of preparation thereof
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
US20030095928A1
(en)
*
|
2001-09-19 |
2003-05-22 |
Elan Pharma International Limited |
Nanoparticulate insulin
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
AU2002337692B2
(en)
|
2001-09-26 |
2007-09-13 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
MXPA04002652A
(en)
*
|
2001-09-26 |
2004-06-07 |
Pharmacia Corp |
Organoleptically acceptable intraorally disintegrating compositions.
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
WO2003030876A1
(en)
*
|
2001-10-10 |
2003-04-17 |
Pharmacia Corporation |
Intraorally disintegrating valdecoxib compositions prepared by spray drying process
|
DE60222160T2
(en)
*
|
2001-10-12 |
2008-06-12 |
Elan Pharma International Ltd., Athlone |
COMPOSITIONS COMPRISING PROPERTIES OF IMMEDIATE RELEASE AND CONTROLLED RELEASE
|
MY148466A
(en)
*
|
2001-10-26 |
2013-04-30 |
Merck Frosst Canada Ltd |
Granule formulation
|
CA2363528A1
(en)
*
|
2001-11-19 |
2003-05-19 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Immediate release tablet containing naproxen sodium
|
AU2002346472A1
(en)
*
|
2001-11-20 |
2003-06-10 |
Advanced Inhalation Research, Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
FR2834889B1
(en)
*
|
2002-01-18 |
2004-04-02 |
Roquette Freres |
SOLID ORODISPERSIBLE PHARMACEUTICAL FORM
|
CA2474835A1
(en)
*
|
2002-02-01 |
2003-08-07 |
Pfizer Products Inc. |
Immediate release dosage forms containing solid drug dispersions
|
AU2003210517A1
(en)
|
2002-02-04 |
2003-09-02 |
Elan Pharma International, Ltd. |
Drug nanoparticles with lysozyme surface stabiliser
|
US6941948B2
(en)
*
|
2002-03-07 |
2005-09-13 |
Vectura Drug Delivery |
Medicament storage and delivery devices
|
EP1490030B2
(en)
*
|
2002-03-20 |
2010-07-14 |
Elan Pharma International Limited |
Nanoparticulate compositions of angiogenesis inhibitors
|
US20050191357A1
(en)
*
|
2002-03-20 |
2005-09-01 |
Yoshiaki Kawashima |
Method of manufacturing chemical-containing composite particles
|
JP2005526095A
(en)
*
|
2002-03-20 |
2005-09-02 |
エラン ファーマ インターナショナル,リミティド |
Rapid dissolution dosage form with low friability
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US7101576B2
(en)
*
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
WO2003086354A1
(en)
|
2002-04-12 |
2003-10-23 |
Elan Pharma International Ltd. |
Nanoparticulate megestrol formulations
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US6592852B1
(en)
*
|
2002-04-25 |
2003-07-15 |
Unilever Home & Personal Care Usa, Division Of Conopco, Inc. |
Zinc citrate beads in oral compositions
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
ATE419835T1
(en)
*
|
2002-05-06 |
2009-01-15 |
Elan Pharma Int Ltd |
NYSTATIN NANOPARTICLE COMPOSITIONS
|
US20030215498A1
(en)
*
|
2002-05-17 |
2003-11-20 |
Harland Ronald S. |
Rapidly disintegrating comressed tablets comprising biologically active compounds
|
US7763278B2
(en)
*
|
2002-06-10 |
2010-07-27 |
Elan Pharma International Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
US20030228370A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Michel Serpelloni |
Orodispersible solid pharmaceutical form
|
EP1551457A1
(en)
*
|
2002-07-16 |
2005-07-13 |
Elan Pharma International Limited |
Liquid dosage compositions of stable nanoparticulate active agents
|
US7445796B2
(en)
*
|
2002-08-19 |
2008-11-04 |
L. Perrigo Company |
Pharmaceutically active particles of a monomodal particle size distribution and method
|
DE60334924D1
(en)
*
|
2002-09-11 |
2010-12-23 |
Elan Pharma Int Ltd |
ANOTEILCHENGRÖSSE
|
WO2004032980A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
EP1569622A1
(en)
*
|
2002-11-25 |
2005-09-07 |
Purdue Research Foundation |
Mannose-based fast dissolving tablets
|
WO2004058216A2
(en)
*
|
2002-12-17 |
2004-07-15 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
AU2003302329B2
(en)
|
2002-12-30 |
2010-01-07 |
Novartis Ag |
Prefilming atomizer
|
US8367111B2
(en)
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
JP4469846B2
(en)
*
|
2003-01-31 |
2010-06-02 |
エラン ファーマ インターナショナル,リミティド |
Nanoparticulate topiramate formulation
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
US8512727B2
(en)
*
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
ES2311806T3
(en)
|
2003-03-07 |
2009-02-16 |
Schering Corporation |
AZETIDINONA COMPOSITE SUBSTITUTED, FORNULATIONS AND USES OF THE SAME FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA.
|
EP1601669B1
(en)
|
2003-03-07 |
2008-12-24 |
Schering Corporation |
Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
|
US7749533B2
(en)
*
|
2003-05-07 |
2010-07-06 |
Akina, Inc. |
Highly plastic granules for making fast melting tablets
|
EP1624862B1
(en)
|
2003-05-08 |
2014-12-31 |
Nektar Therapeutics |
Particulate materials
|
JP2007501683A
(en)
*
|
2003-05-22 |
2007-02-01 |
エラン ファーマ インターナショナル リミテッド |
Sterilization of nanoparticle active substance dispersions by gamma irradiation
|
US20060226234A1
(en)
*
|
2003-06-11 |
2006-10-12 |
Kettinger Frederick R |
Pharmaceutical dosage forms having overt and covert markings for identification and authentification
|
FR2858556B1
(en)
*
|
2003-08-06 |
2006-03-10 |
Galenix Innovations |
DISPERSIBLE AND / OR ORODISPERSIBLE SOLID PHARMACEUTICAL COMPOSITION, NOT PELLETIZED, CONTAINING AT LEAST THE METFORMIN ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE SAME
|
CA2534924A1
(en)
*
|
2003-08-08 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel metaxalone compositions
|
US20050036977A1
(en)
*
|
2003-08-11 |
2005-02-17 |
Dilip Gole |
Taste-masked resinate and preparation thereof
|
US7390503B1
(en)
|
2003-08-22 |
2008-06-24 |
Barr Laboratories, Inc. |
Ondansetron orally disintegrating tablets
|
US20050053655A1
(en)
*
|
2003-09-05 |
2005-03-10 |
Pharmaceutical Industry Technology And Development Center |
Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same
|
CA2785138A1
(en)
*
|
2003-10-07 |
2005-04-21 |
Andrx Pharmaceuticals Llc |
Rapidly disintegrating formulation
|
US8349361B2
(en)
|
2003-10-15 |
2013-01-08 |
Fuji Chemical Industry Co., Ltd. |
Composition for rapid disintegrating tablet in oral cavity
|
JP3841804B2
(en)
|
2003-10-15 |
2006-11-08 |
富士化学工業株式会社 |
Composition for intraorally rapidly disintegrating tablets
|
WO2005044006A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Battelle Memorial Institute |
Quick dissolving agrochemical products
|
US7879360B2
(en)
*
|
2003-11-05 |
2011-02-01 |
Elan Pharma International, Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
BRPI0418330A
(en)
*
|
2003-12-31 |
2007-05-02 |
Pfizer Prod Inc |
solid compositions of low solubility drugs and poloxamers
|
CA2551254A1
(en)
*
|
2003-12-31 |
2005-07-21 |
Pfizer Products Inc. |
Stabilized pharmaceutical solid compositions of low-solubility drugs, poloxamers, and stabilizing polymers
|
US7785619B2
(en)
*
|
2004-04-08 |
2010-08-31 |
Micro Nutrient, Llc |
Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
|
US20050226906A1
(en)
*
|
2004-04-08 |
2005-10-13 |
Micro Nutrient, Llc |
Nutrient system for individualized responsive dosing regimens
|
US7850987B2
(en)
*
|
2004-04-08 |
2010-12-14 |
Micronutrient, Llc |
Nutrient composition(s) and system(s) for individualized, responsive dosing regimens
|
US20060013873A1
(en)
*
|
2004-07-16 |
2006-01-19 |
Chih-Chiang Yang |
Bioadhesive dosage form of steroids
|
WO2006018954A1
(en)
*
|
2004-08-17 |
2006-02-23 |
Eisai R & D Management Co., Ltd. |
Method for producing dibromofluorobenzene derivative
|
US9895444B2
(en)
|
2004-08-25 |
2018-02-20 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
US20060046962A1
(en)
|
2004-08-25 |
2006-03-02 |
Aegis Therapeutics Llc |
Absorption enhancers for drug administration
|
US9114069B2
(en)
*
|
2004-08-25 |
2015-08-25 |
Aegis Therapeutics, Llc |
Antibacterial compositions for drug administration
|
US20090047347A1
(en)
*
|
2005-07-29 |
2009-02-19 |
Aegis Therapeutics, Inc. |
Compositions for Drug Administration
|
US20140162965A1
(en)
|
2004-08-25 |
2014-06-12 |
Aegis Therapeutics, Inc. |
Compositions for oral drug administration
|
US8747895B2
(en)
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
CA2584957C
(en)
|
2004-10-21 |
2015-08-25 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
CA2587710C
(en)
*
|
2004-11-16 |
2014-10-21 |
Elan Pharma International Ltd. |
Injectable nanoparticulate olanzapine formulations
|
UA89513C2
(en)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Nanoparticulate raloxifene hydrochloride composition
|
WO2006062875A1
(en)
*
|
2004-12-08 |
2006-06-15 |
Merck & Co., Inc. |
Ophthalmic nanoparticulate formulation of a cyclooxygenase-2 selective inhibitor
|
MX2007007342A
(en)
*
|
2004-12-15 |
2007-12-11 |
Elan Pharma Int Ltd |
Nanoparticulate tacrolimus formulations.
|
WO2006069098A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Elan Pharma International Ltd. |
Nanoparticulate bicalutamide formulations
|
AU2012201630B8
(en)
*
|
2004-12-31 |
2014-03-06 |
Iceutica Pty Ltd |
NanoParticle Composition(s) and Method for Synthesis Thereof
|
KR20070118224A
(en)
*
|
2005-01-06 |
2007-12-14 |
엘란 파마 인터내셔널 리미티드 |
Nanoparticulate candesartan formulations
|
EP1853234A2
(en)
|
2005-02-15 |
2007-11-14 |
Elan Pharma International Limited |
Aerosol and injectable formulations of nanoparticulate benzodiazepine
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
CN101175480A
(en)
*
|
2005-03-16 |
2008-05-07 |
伊兰制药国际有限公司 |
Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
|
MX2007011495A
(en)
*
|
2005-03-17 |
2007-12-06 |
Elan Pharma Int Ltd |
Nanoparticulate biphosphonate compositions.
|
EA200702049A1
(en)
*
|
2005-03-23 |
2008-02-28 |
Элан Фарма Интернэшнл Лтд. |
COMPOSITIONS OF CORTICOSTEROID NANOPARTICLES WITH ANTIGISTAMINS
|
MX2007012206A
(en)
|
2005-04-08 |
2007-12-05 |
Ptc Therapeutics Inc |
Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy.
|
AU2006235478B2
(en)
|
2005-04-12 |
2011-07-21 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cyclosporine
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
MX2007012778A
(en)
*
|
2005-04-12 |
2008-01-11 |
Elan Pharma Int Ltd |
Nanoparticulate quinazoline derivative formulations.
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
JP2009517485A
(en)
|
2005-06-08 |
2009-04-30 |
エラン・ファルマ・インターナショナル・リミテッド |
Nanoparticulate and controlled release compositions containing cefditoren
|
AU2006278397B2
(en)
|
2005-08-04 |
2013-01-17 |
Sirtris Pharmaceuticals, Inc. |
Oxazolopyridine derivatives as sirtuin modulators
|
EP2279727A3
(en)
|
2005-09-15 |
2011-10-05 |
Elan Pharma International Limited |
Nanoparticulate aripiprazole formulations
|
WO2007056159A2
(en)
*
|
2005-11-03 |
2007-05-18 |
Redpoint Bio Corporation |
Hydrazone derivatives and uses thereof
|
US7811604B1
(en)
|
2005-11-14 |
2010-10-12 |
Barr Laboratories, Inc. |
Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
|
US8022054B2
(en)
|
2005-11-28 |
2011-09-20 |
Marinus Pharmaceuticals |
Liquid ganaxolone formulations and methods for the making and use thereof
|
JP3884056B1
(en)
*
|
2006-01-27 |
2007-02-21 |
秋山錠剤株式会社 |
Method for producing intraoral rapidly disintegrating tablet
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
US20070243248A1
(en)
*
|
2006-04-14 |
2007-10-18 |
Cherukuri S Rao |
Rapidly disintegrating solid oral dosage form of liquid dispersions
|
US8226949B2
(en)
|
2006-06-23 |
2012-07-24 |
Aegis Therapeutics Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
AU2007265452A1
(en)
*
|
2006-06-26 |
2008-01-03 |
Mutual Pharmaceutical Company, Inc. |
Active agent formulations, methods of making, and methods of use
|
JP5508003B2
(en)
*
|
2006-06-30 |
2014-05-28 |
アイスイティカ ピーティーワイ リミテッド |
Process for the preparation of biologically active compounds in nanoparticulate form
|
US20080031947A1
(en)
*
|
2006-07-24 |
2008-02-07 |
Cima Labs Inc. |
Orally dissolvable/disintegrable lyophilized dosage forms containing protected
|
EP1891938A1
(en)
*
|
2006-07-24 |
2008-02-27 |
Cephalon France |
High dose orally dissolvable/disintegrable lyophilized dosage form
|
SG160335A1
(en)
*
|
2006-08-22 |
2010-04-29 |
Redpoint Bio Corp |
Heterocyclic compounds as sweetener enhancers
|
US8124598B2
(en)
|
2006-09-14 |
2012-02-28 |
Sharon Sageman |
7-keto DHEA for psychiatric use
|
WO2008033545A2
(en)
*
|
2006-09-15 |
2008-03-20 |
Redpoint Bio Corporation |
Triphenylphosphine oxide derivatives and uses thereof
|
US20080153845A1
(en)
*
|
2006-10-27 |
2008-06-26 |
Redpoint Bio Corporation |
Trpv1 antagonists and uses thereof
|
AU2007325628A1
(en)
*
|
2006-11-28 |
2008-06-05 |
Marinus Pharmaceuticals |
Nanoparticulate formulations and methods for the making and use thereof
|
EP2124900B1
(en)
*
|
2006-12-20 |
2014-12-03 |
Teva Women's Health, Inc. |
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
EP1935405A1
(en)
*
|
2006-12-22 |
2008-06-25 |
LEK Pharmaceuticals D.D. |
Orally disintegrating tablets
|
CA2677230A1
(en)
*
|
2007-02-02 |
2008-08-14 |
Redpoint Bio Corporation |
Use of a trpm5 inhibitor to regulate insulin and glp-1 release
|
JP3967767B1
(en)
*
|
2007-02-08 |
2007-08-29 |
秋山錠剤株式会社 |
Method for producing intraoral rapidly disintegrating tablet
|
MX2009008582A
(en)
|
2007-02-11 |
2009-10-30 |
Map Pharmaceuticals Inc |
Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile.
|
US20090004231A1
(en)
|
2007-06-30 |
2009-01-01 |
Popp Shane M |
Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
|
EP2180873B1
(en)
|
2007-07-25 |
2018-04-11 |
3M Innovative Properties Company |
Therapeutic dental composition for use in the inhibition of biofilm formation in the oral cavity.
|
US20100160274A1
(en)
*
|
2007-09-07 |
2010-06-24 |
Sharon Sageman |
7-KETO DHEA for Psychiatric Use
|
CA2710293A1
(en)
*
|
2007-12-20 |
2009-07-02 |
Teva Women's Health, Inc. |
Dosage regimens and pharmaceutical compositions and packages for emergency contraception
|
JP5613657B2
(en)
|
2008-03-28 |
2014-10-29 |
ヘイル バイオファーマ ベンチャーズ,エルエルシー |
Administration of benzodiazepine composition
|
WO2009124357A1
(en)
*
|
2008-04-10 |
2009-10-15 |
Malvin Leonard Eutick |
Fast dissolving oral formulations for critical drugs
|
AU2009240586A1
(en)
*
|
2008-04-24 |
2009-10-29 |
Evestra, Inc. |
Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
|
KR101647855B1
(en)
*
|
2008-06-20 |
2016-08-11 |
메르크 파텐트 게엠베하 |
Directly injection moldable and rapidly disintegrating tablet matrix
|
DE102008047910A1
(en)
|
2008-09-19 |
2010-03-25 |
Molkerei Meggle Wasserburg Gmbh & Co. Kg |
Tabletting excipient based on lactose and cellulose
|
WO2010077878A1
(en)
*
|
2008-12-15 |
2010-07-08 |
Fleming And Company, Pharmaceuticals |
Rapidly dissolving vitamin formulation and methods of using the same
|
US8440631B2
(en)
|
2008-12-22 |
2013-05-14 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
US20100159010A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
BRPI1014275B8
(en)
|
2009-04-24 |
2021-05-25 |
Iceutica Pty Ltd |
composition comprising indomethacin particles dispersed in at least two partially ground mill materials
|
EP2253306A1
(en)
|
2009-05-18 |
2010-11-24 |
Royal College of Surgeons in Ireland |
Orodispersible dosage forms containing solid drug dispersions
|
HUE032426T2
(en)
|
2009-05-27 |
2017-09-28 |
Alkermes Pharma Ireland Ltd |
Reduction of flake-like aggregation in nanoparticulate meloxicam compositions
|
FR2945950A1
(en)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
ANTICANCER NANOPARTICLE COMPOSITIONS AND METHODS FOR PREPARING THE SAME
|
WO2011028671A1
(en)
|
2009-09-04 |
2011-03-10 |
Redpoint Bio Corporation |
Sweetness enhancers including rebaudioside a or d
|
US9775819B2
(en)
*
|
2009-09-16 |
2017-10-03 |
R.P. Scherer Technologies, Llc |
Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
|
CN102595932B
(en)
|
2009-09-22 |
2014-07-16 |
红点生物公司 |
Novel polymorphs of rebaudioside C and methods for making and using the same
|
WO2011067667A2
(en)
|
2009-12-02 |
2011-06-09 |
Eurand Pharmaceuticals Limited |
Fexofenadine microcapsules and compositions containing them
|
US9012511B2
(en)
|
2010-05-19 |
2015-04-21 |
Alkermes Pharma Ireland Limited |
Nanoparticulate cinacalcet compositions
|
JP2013536858A
(en)
|
2010-09-01 |
2013-09-26 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
Fast-dissolving dosage form of 5-HT2C agonist
|
US10238684B2
(en)
|
2010-11-18 |
2019-03-26 |
Foundational Biosystems, Llc |
Micro- and nano-quantity sleep enhancing nutrient composition and method of enhancing central nervous system protein clearance using same
|
MX350838B
(en)
|
2011-02-11 |
2017-09-18 |
Grain Proc Corporation * |
Salt composition.
|
CN107737100A
(en)
|
2011-06-14 |
2018-02-27 |
哈尔生物药投资有限责任公司 |
The administration of Benzodiazepine composition
|
CN108570464B
(en)
|
2011-08-08 |
2021-12-21 |
国际香料香精公司 |
Compositions and methods for the biosynthesis of vanillin or vanillin beta-D-glucoside
|
TWI526210B
(en)
*
|
2012-02-15 |
2016-03-21 |
Taiho Pharmaceutical Co Ltd |
Oral pharmaceutical composition
|
JP5877778B2
(en)
*
|
2012-05-28 |
2016-03-08 |
株式会社ホットアルバム炭酸泉タブレット |
Tablet manufacturing method and tablet
|
CN105050585A
(en)
*
|
2013-03-04 |
2015-11-11 |
Vtv治疗有限责任公司 |
Stable glucokinase activator compositions
|
KR101890649B1
(en)
*
|
2013-07-30 |
2018-09-28 |
라이온 가부시키가이샤 |
Tablet
|
KR102307175B1
(en)
|
2013-09-16 |
2021-10-01 |
아스트라제네카 아베 |
Therapeutic polymeric nanoparticles and methods of making and using same
|
EP3068396B1
(en)
|
2013-11-11 |
2019-05-08 |
Impax Laboratories, Inc. |
Rapidly disintegrating formulations and methods of use
|
EP2880992A3
(en)
|
2013-12-05 |
2015-06-17 |
International Flavors & Fragrances Inc. |
Rebaudioside C and its stereoisomers as natural product sweetness enhancers
|
RU2015112640A
(en)
*
|
2014-02-07 |
2017-02-28 |
Сайлабс Фармасьютикалс |
FULLY NATURAL NON-TOXIC SUBLINGUAL MEDICINAL DELIVERY SYSTEMS
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
WO2016025911A1
(en)
*
|
2014-08-14 |
2016-02-18 |
Brown University |
Compositions for stabilizing and delivering proteins
|
SG11201703896QA
(en)
|
2014-11-21 |
2017-06-29 |
Biohaven Pharm Holding Co Ltd |
Sublingual formulation of riluzole
|
US9925138B2
(en)
|
2015-01-20 |
2018-03-27 |
Handa Pharmaceuticals, Llc |
Stable solid fingolimod dosage forms
|
EP3288556A4
(en)
|
2015-04-29 |
2018-09-19 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
MX2017013956A
(en)
|
2015-05-01 |
2018-09-05 |
Cocrystal Pharma Inc |
Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer.
|
US11110035B1
(en)
|
2016-02-05 |
2021-09-07 |
Gram Tactical Llc |
Tactical medicine dispensers
|
MX2018013868A
(en)
|
2016-05-20 |
2019-02-21 |
Biohaven Pharm Holding Co Ltd |
Use of glutamate modulating agents with immunotherapies to treat cancer.
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
WO2018031748A1
(en)
|
2016-08-11 |
2018-02-15 |
Ovid Therapeutics Inc. |
Methods and compositions for treatment of epileptic disorders
|
BR112019013503A2
(en)
|
2016-12-31 |
2020-01-07 |
Bioxcel Therapeutics, Inc. |
USE OF SUBLINGUAL DEXMEDETOMIDINE TO TREAT AGITATION
|
JP2019077644A
(en)
*
|
2017-10-25 |
2019-05-23 |
富士フイルム株式会社 |
Pharmaceutical composition and method of producing pharmaceutical composition
|
KR20200103658A
(en)
|
2017-11-12 |
2020-09-02 |
바이오하벤 파마슈티컬 홀딩 컴퍼니 엘티디. |
Use of riluzole prodrugs to treat ataxia
|
EP3508199A1
(en)
*
|
2018-01-05 |
2019-07-10 |
Dompé farmaceutici S.p.A. |
Immediate-release pharmaceutical compositions containing ketoprofen lysine salt
|
CN114983981A
(en)
|
2018-06-27 |
2022-09-02 |
比奥克斯塞尔医疗股份有限公司 |
Dexmedetomidine-containing film preparation and method for producing the same
|
CN109125775B
(en)
*
|
2018-09-25 |
2021-02-09 |
广东爱车小屋电子商务科技有限公司 |
Air freshener with lasting fragrance and preparation method thereof
|
WO2020118142A1
(en)
|
2018-12-07 |
2020-06-11 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of pospartum depression
|
MX2022000709A
(en)
|
2019-07-19 |
2022-05-19 |
Bioxcel Therapeutics Inc |
Non-sedating dexmedetomidine treatment regimens.
|
MX2022001553A
(en)
|
2019-08-05 |
2022-04-18 |
Marinus Pharmaceuticals Inc |
Ganaxolone for use in treatment of status epilepticus.
|
WO2021113834A1
(en)
|
2019-12-06 |
2021-06-10 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in treating tuberous sclerosis complex
|
EP4142699A1
(en)
|
2020-04-30 |
2023-03-08 |
Nanocopoeia LLC |
Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib
|
CA3178769A1
(en)
|
2020-05-18 |
2021-11-25 |
Jonas Savmarker |
New pharmaceutical composition for drug delivery
|
EP3928772A1
(en)
|
2020-06-26 |
2021-12-29 |
Algiax Pharmaceuticals GmbH |
Nanoparticulate composition
|
IT202000025885A1
(en)
*
|
2020-10-30 |
2022-04-30 |
Vacutest Kima S R L |
URINE PRESERVATIVE COMPOSITION, URINE SAMPLING DEVICE AND METHOD FOR PRODUCTION OF URINE SAMPLING DEVICE
|
US11672761B2
(en)
|
2020-11-16 |
2023-06-13 |
Orcosa Inc. |
Rapidly infusing platform and compositions for therapeutic treatment in humans
|
AR127780A1
(en)
|
2021-11-25 |
2024-02-28 |
Orexo Ab |
NEW PHARMACEUTICAL COMPOSITION THAT COMPRISES ADRENALINE
|